位置:首页 > 蛋白库 > PHAR2_HUMAN
PHAR2_HUMAN
ID   PHAR2_HUMAN             Reviewed;         634 AA.
AC   O75167; A6NKP5; A7MCZ5; A8MZC0; B2RWP7; B4DN76; B4DPB5; B4DTH7; Q5TFA0;
AC   Q68DM2;
DT   09-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   03-AUG-2022, entry version 151.
DE   RecName: Full=Phosphatase and actin regulator 2;
GN   Name=PHACTR2; Synonyms=C6orf56, KIAA0680;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-165.
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Kidney, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-165.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; THR-25; SER-522 AND
RP   SER-560, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-25, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   MYRISTOYLATION AT GLY-2 (ISOFORMS 2 AND 4), CLEAVAGE OF INITIATOR
RP   METHIONINE (ISOFORMS 2 AND 4), AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25807930; DOI=10.1002/anie.201500342;
RA   Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J., Magee A.I.,
RA   Tate E.W.;
RT   "Multifunctional reagents for quantitative proteome-wide analysis of
RT   protein modification in human cells and dynamic profiling of protein
RT   lipidation during vertebrate development.";
RL   Angew. Chem. Int. Ed. 54:5948-5951(2015).
CC   -!- SUBUNIT: Binds PPP1CA and actin. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O75167; P16333: NCK1; NbExp=2; IntAct=EBI-1754409, EBI-389883;
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O75167-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75167-2; Sequence=VSP_012272, VSP_012273;
CC       Name=4;
CC         IsoId=O75167-4; Sequence=VSP_012272;
CC       Name=5;
CC         IsoId=O75167-5; Sequence=VSP_012273;
CC   -!- SIMILARITY: Belongs to the phosphatase and actin regulator family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31655.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG60527.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB014580; BAA31655.2; ALT_INIT; mRNA.
DR   EMBL; AK297799; BAG60138.1; -; mRNA.
DR   EMBL; AK298263; BAG60527.1; ALT_SEQ; mRNA.
DR   EMBL; AK300221; BAG61989.1; -; mRNA.
DR   EMBL; CR749345; CAH18198.1; -; mRNA.
DR   EMBL; AL049844; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL078593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC150630; AAI50631.1; -; mRNA.
DR   EMBL; BC152416; AAI52417.1; -; mRNA.
DR   CCDS; CCDS43512.1; -. [O75167-5]
DR   CCDS; CCDS47492.1; -. [O75167-1]
DR   CCDS; CCDS47493.1; -. [O75167-4]
DR   CCDS; CCDS47494.1; -. [O75167-2]
DR   PIR; T00359; T00359.
DR   RefSeq; NP_001093634.1; NM_001100164.1. [O75167-4]
DR   RefSeq; NP_001093635.1; NM_001100165.1. [O75167-2]
DR   RefSeq; NP_001093636.1; NM_001100166.1. [O75167-5]
DR   RefSeq; NP_055536.2; NM_014721.2. [O75167-1]
DR   AlphaFoldDB; O75167; -.
DR   SMR; O75167; -.
DR   BioGRID; 115097; 19.
DR   IntAct; O75167; 18.
DR   MINT; O75167; -.
DR   STRING; 9606.ENSP00000417038; -.
DR   GlyGen; O75167; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75167; -.
DR   PhosphoSitePlus; O75167; -.
DR   BioMuta; PHACTR2; -.
DR   CPTAC; CPTAC-989; -.
DR   EPD; O75167; -.
DR   jPOST; O75167; -.
DR   MassIVE; O75167; -.
DR   MaxQB; O75167; -.
DR   PaxDb; O75167; -.
DR   PeptideAtlas; O75167; -.
DR   PRIDE; O75167; -.
DR   ProteomicsDB; 49831; -. [O75167-1]
DR   ProteomicsDB; 49832; -. [O75167-2]
DR   ProteomicsDB; 49833; -. [O75167-4]
DR   ProteomicsDB; 49834; -. [O75167-5]
DR   Antibodypedia; 33158; 93 antibodies from 17 providers.
DR   DNASU; 9749; -.
DR   Ensembl; ENST00000305766.10; ENSP00000305530.6; ENSG00000112419.15. [O75167-5]
DR   Ensembl; ENST00000367582.7; ENSP00000356554.3; ENSG00000112419.15. [O75167-2]
DR   Ensembl; ENST00000427704.6; ENSP00000391763.2; ENSG00000112419.15. [O75167-1]
DR   Ensembl; ENST00000440869.7; ENSP00000417038.2; ENSG00000112419.15. [O75167-4]
DR   GeneID; 9749; -.
DR   KEGG; hsa:9749; -.
DR   MANE-Select; ENST00000440869.7; ENSP00000417038.2; NM_001100164.2; NP_001093634.1. [O75167-4]
DR   UCSC; uc003qjq.4; human. [O75167-1]
DR   CTD; 9749; -.
DR   DisGeNET; 9749; -.
DR   GeneCards; PHACTR2; -.
DR   HGNC; HGNC:20956; PHACTR2.
DR   HPA; ENSG00000112419; Group enriched (choroid plexus, placenta).
DR   MIM; 608724; gene.
DR   neXtProt; NX_O75167; -.
DR   OpenTargets; ENSG00000112419; -.
DR   PharmGKB; PA134944445; -.
DR   VEuPathDB; HostDB:ENSG00000112419; -.
DR   eggNOG; KOG4339; Eukaryota.
DR   GeneTree; ENSGT00940000157628; -.
DR   HOGENOM; CLU_015753_2_0_1; -.
DR   InParanoid; O75167; -.
DR   OMA; PSHKGDE; -.
DR   OrthoDB; 1205245at2759; -.
DR   PhylomeDB; O75167; -.
DR   TreeFam; TF316316; -.
DR   PathwayCommons; O75167; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   SignaLink; O75167; -.
DR   BioGRID-ORCS; 9749; 11 hits in 1078 CRISPR screens.
DR   ChiTaRS; PHACTR2; human.
DR   GenomeRNAi; 9749; -.
DR   Pharos; O75167; Tbio.
DR   PRO; PR:O75167; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O75167; protein.
DR   Bgee; ENSG00000112419; Expressed in placenta and 205 other tissues.
DR   ExpressionAtlas; O75167; baseline and differential.
DR   Genevisible; O75167; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031092; C:platelet alpha granule membrane; TAS:Reactome.
DR   GO; GO:0003779; F:actin binding; IBA:GO_Central.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   InterPro; IPR029991; Phactr2.
DR   InterPro; IPR004018; RPEL_repeat.
DR   PANTHER; PTHR12751:SF5; PTHR12751:SF5; 1.
DR   Pfam; PF02755; RPEL; 2.
DR   SMART; SM00707; RPEL; 4.
DR   PROSITE; PS51073; RPEL; 4.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Lipoprotein; Membrane; Myristate;
KW   Phosphoprotein; Protein phosphatase inhibitor; Reference proteome; Repeat.
FT   CHAIN           1..634
FT                   /note="Phosphatase and actin regulator 2"
FT                   /id="PRO_0000126636"
FT   REPEAT          60..85
FT                   /note="RPEL 1"
FT   REPEAT          477..502
FT                   /note="RPEL 2"
FT   REPEAT          515..540
FT                   /note="RPEL 3"
FT   REPEAT          553..578
FT                   /note="RPEL 4"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          83..344
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          412..471
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          485..508
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..146
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        216..263
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        276..292
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        324..340
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        428..442
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        448..464
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         25
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P62025"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..4
FT                   /note="MDNA -> MGQTSVSTLSPQPGS (in isoform 2 and isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012272"
FT   VAR_SEQ         141..220
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012273"
FT   VARIANT         165
FT                   /note="P -> S (in dbSNP:rs2073214)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9734811"
FT                   /id="VAR_045628"
FT   VARIANT         449
FT                   /note="I -> V (in dbSNP:rs2295201)"
FT                   /id="VAR_053646"
FT   CONFLICT        197
FT                   /note="T -> I (in Ref. 5; AAI50631)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        436
FT                   /note="R -> K (in Ref. 2; BAG60138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        558
FT                   /note="K -> R (in Ref. 2; BAG60138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        610
FT                   /note="E -> G (in Ref. 2; BAG60138)"
FT                   /evidence="ECO:0000305"
FT   INIT_MET        O75167-2:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   LIPID           O75167-2:2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   INIT_MET        O75167-4:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25807930"
FT   LIPID           O75167-4:2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25807930"
SQ   SEQUENCE   634 AA;  69700 MW;  B45A5C5F2E389779 CRC64;
     MDNAVDGLDK ASIANSDGPT AGSQTPPFKR KGKLSTIGKI FKPWKWRKKK TSDKFRETSA
     VLERKISTRQ SREELIRRGV LKELPDQDGD VTVNFENSNG HMIPIGEEST REENVVKSEE
     GNGSVSEKTP PLEEQAEDKK ENTENHSETP AAPALPPSAP PKPRPKPKPK KSPVPPKGAT
     AGASHKGDEV PPIKKNTKAP GKQAPVPPPK PASRNTTREA AGSSHSKKTT GSKASASPST
     SSTSSRPKAS KETVSSKAGT VGTTKGKRKT DKQPITSHLS SDTTTSGTSD LKGEPAETRV
     ESFKLEQTVP GAEEQNTGKF KSMVPPPPVA PAPSPLAPPL PLEDQCITAS DTPVVLVSVG
     ADLPVSALDP SQLLWAEEPT NRTTLYSGTG LSVNRENAKC FTTKEELGKT VPQLLTPGLM
     GESSESFSAS EDEGHREYQA NDSDSDGPIL YTDDEDEDED EDGSGESALA SKIRRRDTLA
     IKLGNRPSKK ELEDKNILQR TSEEERQEIR QQIGTKLVRR LSQRPTTEEL EQRNILKQKN
     EEEEQEAKME LKRRLSRKLS LRPTVAELQA RRILRFNEYV EVTDSPDYDR RADKPWARLT
     PADKAAIRKE LNEFKSTEME VHEESRQFTR FHRP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024